Iterum Therapeutics (ITRM) Total Debt (2018 - 2022)
Historic Total Debt for Iterum Therapeutics (ITRM) over the last 5 years, with Q3 2022 value amounting to $9.9 million.
- Iterum Therapeutics' Total Debt fell 3531.37% to $9.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $9.9 million, marking a year-over-year decrease of 3531.37%. This contributed to the annual value of $13.0 million for FY2021, which is 7469.56% down from last year.
- Latest data reveals that Iterum Therapeutics reported Total Debt of $9.9 million as of Q3 2022, which was down 3531.37% from $10.1 million recorded in Q2 2022.
- Iterum Therapeutics' Total Debt's 5-year high stood at $51.3 million during Q4 2020, with a 5-year trough of $9.9 million in Q3 2022.
- For the 5-year period, Iterum Therapeutics' Total Debt averaged around $23.9 million, with its median value being $14.3 million (2019).
- In the last 5 years, Iterum Therapeutics' Total Debt surged by 28232.4% in 2020 and then tumbled by 7469.56% in 2021.
- Over the past 5 years, Iterum Therapeutics' Total Debt (Quarter) stood at $14.1 million in 2018, then fell by 4.77% to $13.4 million in 2019, then soared by 282.32% to $51.3 million in 2020, then crashed by 74.7% to $13.0 million in 2021, then decreased by 23.71% to $9.9 million in 2022.
- Its last three reported values are $9.9 million in Q3 2022, $10.1 million for Q2 2022, and $12.2 million during Q1 2022.